Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.066
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2013
Authors
Publisher
Elsevier BV